Here We Go Again: Novartis Fined for Off-Label Marketing

2010-10-03T09:06:59Z

...

A.M. Vitals: Genzyme Rejects Takeover Offer From Sanofi-Aventis

2010-11-02T14:14:50Z

...

Okla. Joins Wyeth Drug Pricing Case

2010-11-02T12:39:35Z

...

Drugmakers post higher 1st-quarter profits, sales

2010-09-22T13:39:29Z

Three drugmakers post improved 1st-quarter profits and sales, rest of year looks less rosy

Three top drugmakers on Thursday posted healthy increases in first-quarter sales and profits, with strong sales of key drugs buoying Bristol-Myers Squibb Co., AstraZeneca LP and Amgen Inc.'s first-quarter profit beat Wall Street expectations as sales of its anti-infection drugs improved. However the company said 2010 results will come in at the low end of its forecast due to health reform costs.

DISCOUNTS: Amgen said new requirements under the reform bill will cost it $200 million to $250 million this year. Among other provisions, ...

Drug Companies Agree to $7.75 Million Settlement With State

2010-10-25T20:42:34Z

...

Drugmaker settles price-fraud lawsuit with Wis.

2010-04-20T11:45:51Z

German drugmaker, state of Wisconsin reach $7.75M settlement on suit alleging Medicaid fraud

A German-based pharmaceutical company has agreed to pay $7.75 million to settle allegations that four of its subsidiaries committed price fraud, Wisconsin Attorney General J.B. Van Hollen said Tuesday.

The fou...

THE INFLUENCE GAME: Drug lobby's health care win

2010-03-29T03:45:23Z

THE INFLUENCE GAME: Lobbying pays off as drug industry hits jackpot with health overhaul.

Chalk one up for the pharmaceutical lobby. The U.S. drug industry fended off price curbs and other hefty restrictions in President Barack Obama's health care law even as it prepares for plenty of new business when an estimated 32 million uninsured Americans gain h...

NJ drug company agrees to pay $3.5 settlement

2010-04-16T07:00:12Z

NJ drug company agrees to pay $3.5 settlement with federal authorities

Federal prosecutors say a New Jersey pharmaceutical company has agreed to pay $3.5 million to settle allegations that it claimed its heart drug was eligible for Medicaid reimbursement.

The U.S. attorney's office in

Teva Pharma Settles Some Medicaid Drug Price Suits

2010-10-24T15:17:56Z

...

GlaxoSmithKline Fined $5.8 Million for Deceptive Marketing in Kentucky

2010-10-24T15:17:52Z

...

15 states sue Amgen alleging kickback scheme

2010-04-16T09:30:53Z

15 states sue Amgen, alleging kickback scheme to boost sales of anemia drug Aranesp

Biotechnology behemoth Amgen Inc. is being sued by 15 states alleging the company gave kickbacks to medical providers to help boost sales of the anemia drug Aranesp.

The Wyoming to collect nearly $50,000 from 4 pharmaceutical companies for alleged Medicaid fraud

Four pharmaceutical companies have reached a nearly $50,000 settlement with the state of Wyoming for allegedly submitting false claims to the Medicaid program.

Wyoming Att...

Mylan to pay $121M to end Medicaid generic claims

2010-04-16T09:45:46Z

Mylan Inc. and two other drugmakers will pay $124 million to settle claims they did not properly reimburse Medicaid for drugs, officials said Monday.

New York Attorney General Andrew Cuomo said two Mylan subsidiaries, along with one division of AstraZeneca PLC and...

Ala. court rejects $274M verdicts in drug cases

2010-04-16T09:48:14Z

The Alabama Supreme Court on Friday threw out jury decisions awarding the state more than $274 million from three pharmaceutical companies, ruling they did not defraud the state in pricing Medicaid prescription drugs.

The court overturned jury verdicts against the drug companies AstraZeneca,

Kentucky Attorney General Conway Announces $14.7 Million Verdict Against Drug Company

2010-10-24T09:17:00Z

...

Jury: $14.7M verdict against AstraZeneca

2010-06-12T12:31:25Z

Kentucky court says drugmaker inflated prices; AstraZeneca must reimburse state $14.7M

A Kentucky jury has hit British drugmaker AstraZeneca PLC with a $14.7 million verdict in a case that claimed the company inflated its prescription drug prices for Medicaid reimbursements.

Medicom joins GlobalCom to aid expansion

2010-10-22T12:03:45Z

...

Health care issues: Proposed drug industry savings

2010-04-16T10:20:47Z

A look at key issues in the health care debate:

THE ISSUE: Is the pharmaceutical industry's agreement to lower drug costs by $80 billion over the next decade fair?

THE POLITICS: The industry's trade group, the Pharmaceutical Research and Manufacturers of America, agreed to contribute those savings to help pay for Closing arguments end in Ala. lawsuit accusing drug company of overcharging Medicaid programs

Closing arguments have ended in the state of Alabama's lawsuit against a California-based drug maker accused of cheating the state's Medicaid program out of millions of dollars.

State attorney

Sanofi-aventis U.S. Announces Settlement of Medicaid 'Best Price' Investigation

2010-10-24T09:14:39Z

...

Drugmaker to pay nearly $100 million settlement

2010-06-11T22:03:16Z

Drugmaker Aventis to pay US, states nearly $100 million to settle Medicaid drug pricing case

Drugmaker Sanofi-Aventis has agreed to pay nearly $100 million to settle allegations it cheated Medicaid on the cost of nasal sprays.

The Reuters) - The U.S. Justice Department said on Monday that it and 16 states had joined two whistleblower lawsuits filed against Wyeth which allege the drugmaker failed to pay hundreds of millions of dollars in rebates to Medicaid.

The lawsuits accuse Wyeth of giving hospitals...

Feds Join Lawsuits Against Wyeth on Protonix Prices

2010-10-24T09:55:59Z

...

US: Drugmaker Wyeth cheated Medicaid

2010-04-16T12:15:14Z

US charges drugmaker Wyeth cheated Medicaid out of millions of dollars

The Justice Department on Monday accused Wyeth, one of the nation's biggest drugmakers, of cheating Medicaid programs out of hundreds of millions of dollars by overcharging for a stomach acid drug.

The Justice Department and more than a dozen states have join...

Jury orders $78.4M judgment in drug-pricing trial

2010-04-16T14:06:34Z

Jurors ordered the German-based pharmaceutical company Sandoz Inc. on Tuesday to pay Alabama $78.4 million for causing the state Medicaid program to pay too much for prescription drugs from 1991 to 2005.

The jury ordered Sandoz, a subsidiary of Novartis AG, to pay $28.4 million to co...

Alabama settles suits against 5 drug companies

2010-04-16T16:43:43Z

Alabama settles prescription drug suits against Bristol-Myers Squibb, 4 other companies

The state of Alabama has settled Medicaid drug pricing lawsuits it filed against prescription drug manufacturer Bristol-Myers Squibb and four other companies, a lawyer representing the state conf...

Blowing the whistle

2010-04-16T13:30:33Z

Congress should expand the law that has helped recoup billions from health care fraud

In the 1990s the Justice Department started relying on whistleblowers in private industry to combat health care fraud in the Medicare and Medicaid programs.

A study recently published in the

2 drug firms to appeal $114M price fraud verdict

2010-06-12T00:09:48Z

GlaxoSmithKline, Novartis to appeal $114 million verdict in Alabama drug price lawsuits

Two large pharmaceutical companies said Thursday they will appeal a jury verdict ordering them to pay more than $114 million for overcharging the state's Medicaid<...

Novartis to appeal decision in Alabama drug pricing suit

2010-10-23T09:54:14Z

...

Jury: 2 drug firms owe Ala. $114M in price fraud

2010-04-16T17:00:40Z

A jury has ordered two pharmaceutical companies to pay $114 million to Alabama for overcharging for Medicaid prescription drugs.

The jury found that GlaxoSmithKline should pay the state nearly $81 million in compensatory damages and that Novartis should pay more than ...

AstraZeneca to appeal Alabama medicaid pricing case judgement

2010-10-19T10:05:09Z

...

Minn. law sheds light on drug companies

2010-09-09T15:52:20Z

Minn. Law Shines Rare Light Into Big Money Drug Companies Spend on State Advisory Panels

A groundbreaking Minnesota law is shining a rare light into the big money that drug companies spend on members of state advisory panels who help select which drugs are used in Medicaid programs for the poor and disabled.

Those panels, most comprised of physicians, hold great...

Minn. law shines rare light into big money drug companies spend on state advisory panels

2010-09-09T15:48:47Z

Those panels, most comprised of physicians, hold great sway over the $28 billion spent on drugs each year for Medicaid patients nationwide. But aside from Minnesota, o...

MEDICAID CUTS

2010-12-13T12:32:10Z

Chart shows breakdown of percentage of Medicaid costs associated with each enrollment group; and the decade long trend between enrollment and Medicaid spending.

...

Medicaid Cuts Fallout

2010-12-13T12:32:10Z

FILE - In this Dec. 7, 2010, file photo, 13-year-old Carlos Olivas paces in front of the Arizona Capitol in Phoenix to help raise money for his friend Francisco Felix who was denied a liver transplant because Sarrell Dental Center office in a depressed neighborhood in Bessemer, Ala. Sarrell Dental, a non-profit corporation that treats young people on Medicaid, is at odds with the Robert Hansen sells copies of the street paper "Real Change," outside a grocery store in Seattle's Seward Park neighborhood. Hansen and most other poor adults without young children don't qualify for Medicaid. The proposals in Congress would expand Medicaid coverage to people like Hansen. In the leading Senate proposa...

Hospice Cares For Terminally Ill During Final Days

2010-03-31T07:12:56Z

LAKEWOOD, CO - OCTOBER 07: Volunteers assist terminally ill patient Jackie Beattie, 83, back to her room after she released a dove on October 7, 2009 while at the Hospice of Saint John in Denver, Colorado. The dove releases are part of an animal t...

News on Medicaid

Here We Go Again: Novartis Fined for Off-Label Marketing

A.M. Vitals: Genzyme Rejects Takeover Offer From Sanofi-Aventis

Okla. Joins Wyeth Drug Pricing Case

Drugmakers post higher 1st-quarter profits, sales

Drug Companies Agree to $7.75 Million Settlement With State

Drugmaker settles price-fraud lawsuit with Wis.

THE INFLUENCE GAME: Drug lobby's health care win

NJ drug company agrees to pay $3.5 settlement

Teva Pharma Settles Some Medicaid Drug Price Suits

GlaxoSmithKline Fined $5.8 Million for Deceptive Marketing in Kentucky

15 states sue Amgen alleging kickback scheme

Mylan to pay $121M to end Medicaid generic claims

Ala. court rejects $274M verdicts in drug cases

Kentucky Attorney General Conway Announces $14.7 Million Verdict Against Drug Company

Jury: $14.7M verdict against AstraZeneca

Medicom joins GlobalCom to aid expansion

Health care issues: Proposed drug industry savings

Sanofi-aventis U.S. Announces Settlement of Medicaid 'Best Price' Investigation

Drugmaker to pay nearly $100 million settlement

Feds Join Lawsuits Against Wyeth on Protonix Prices

US: Drugmaker Wyeth cheated Medicaid

Jury orders $78.4M judgment in drug-pricing trial

Alabama settles suits against 5 drug companies

Blowing the whistle

2 drug firms to appeal $114M price fraud verdict

Novartis to appeal decision in Alabama drug pricing suit

Jury: 2 drug firms owe Ala. $114M in price fraud

AstraZeneca to appeal Alabama medicaid pricing case judgement

Minn. law sheds light on drug companies

Minn. law shines rare light into big money drug companies spend on state advisory panels

MEDICAID CUTS

Medicaid Cuts Fallout

Hospice Cares For Terminally Ill During Final Days